InSphero & FDA's NCTR Publish the Largest Benchmark Study on DILI Using 3D Liver Microtissues
The study tested 152 FDA-approved drugs, highlighting how 3D liver microtissues improve R&D efficiency by identifying liver-toxic drugs before clinical trials
